![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Wednesday 13 October 2010, 14:00-15:00
Why is genomics now unfashionable in drug discovery?
- đ¤ Speaker: Quin Wills (SimuGen)
- đ Date & Time: Wednesday 13 October 2010, 14:00 - 15:00
- đ Venue: MR4, Centre for Mathematical Sciences, Wilberforce Road, Cambridge
Abstract
The pharmaceutical industry is experiencing a significant innovation crisis. It would seem that the era of ‘big hit’ drugs, science driven by high-throughput chemistry and pharmaceutical companies is nearing an end, with most major drug patents expiring within two years. Only just a few years ago there was enormous excitement around how functional genomics and other ‘high resolution’ technologies would allow systems biology to reinvigorate drug R&D. These days we see a large return to traditional methods, amidst complaints that omics hasn’t truly helped make any decisions but just added to the data burden.
The talk will be a general discussion on current drug discovery trends, ‘big data’ approaches, ‘open-source’ biology, where the problems are, and suggested solutions. As a case study, we will use toxicogenomics software and models developed in-house at SimuGen, a pharmacogenomics company born at CCBI .
Series This talk is part of the Computational and Systems Biology series.
Included in Lists
- All CMS Events
- All Talks (aka the CURE list)
- Biology
- CamBridgeSens
- Cambridge talks
- Computational and Systems Biology
- custom
- Graduate-Seminars
- Life Science Interface Seminars
- Life Sciences
- Life Sciences
- ME Seminar
- MR4, Centre for Mathematical Sciences, Wilberforce Road, Cambridge
- my_list
- other talks
- PMRFPS's
- School of Physical Sciences
- se393's list
- Trust & Technology Initiative - interesting events
- yk449
Note: Ex-directory lists are not shown.